| abstract |
Disclosed is a pharmaceutical and/or diet product, especially for prophylaxis and/or therapy of diseases or disorders caused by insufficient and/or lack of oxygen supply, secondary effects of anti-inflammatory active substances and/or prophylaxis and/or therapy of disorders of the energy metabolism, wherein the pharmaceutical or diet product: a) contains at least one compound, having at least one functional group of the general formula (I): -(CH2)2-NO-(CH3)3, b) and/or having S-adenosyl methionine. |